Cargando…

Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study

BACKGROUND: The Simeprevir ObservatioNal Effectiveness across practice seTtings (SONET) study evaluated the real-world effectiveness of simeprevir-based treatment for hepatitis C virus (HCV) infection. METHODS: The SONET study was a phase 4, prospective, observational, United States–based study enro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, Imtiaz, Brown, Kimberley, Donovan, Cynthia, Forlenza, Jamie, Lauwers, Kris, Mah’moud, Mitchell A., Manch, Richard, Mohanty, Smruti R., Prabhakar, Avinash, Reindollar, Robert, DeMasi, Ralph, Slim, Jihad, Tandon, Neeta, Villadiego, Shirley, Naggie, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413999/ https://www.ncbi.nlm.nih.gov/pubmed/28480251 http://dx.doi.org/10.1093/ofid/ofw258

Ejemplares similares

ATM/SONET explained /
por: Lewis, Sadie, 1952-
Publicado: (1995)

SONET ( Redes ópticas sincronas ) /
por: Alvarez Eslava, Alejandro
Publicado: (2004)

Next Generation SDH/SONET: Evolution or Revolution?
por: Van Helvoort, Huub
Publicado: (2005)

Coupling GSN to SONET-OC48/SDH16
por: Van Praag, A, et al.
Publicado: (2001)

SDH/SONET Explained in Functional Models: Modeling the Optical Transport Network
por: Van Helvoort, Huub
Publicado: (2005)

Connection-oriented Networks: SONET/SDH, ATM, MPLS and Optical Networks
por: Perros, Harry G
Publicado: (2005)

Network recovery: protection and restoration of optical, SONET-SDH, IP, and MPLS
por: Vasseur, Jean-Philippe, et al.
Publicado: (2004)

Use of the SONET score to evaluate Urgent Care Center overcrowding: a prospective pilot study
por: Wang, Hao, et al.
Publicado: (2015)

Simeprevir for the treatment of hepatitis C virus infection
por: Izquierdo, Laure, et al.
Publicado: (2014)

In vitro susceptibility of human Blastocystis subtypes to simeprevir
por: Mossallam, Shereen F., et al.
Publicado: (2021)

Simeprevir restores the anti-Staphylococcus activity of polymyxins
por: Wu, Yuan, et al.
Publicado: (2023)

Use of the SONET Score to Evaluate High Volume Emergency Department Overcrowding: A Prospective Derivation and Validation Study
por: Wang, Hao, et al.
Publicado: (2015)

Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma
por: El Sharkasy, Mona E., et al.
Publicado: (2022)

Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
por: Bichoupan, Kian, et al.
Publicado: (2017)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment
por: Ouwerkerk-Mahadevan, Sivi, et al.
Publicado: (2015)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C
por: Sarkar, Souvik, et al.
Publicado: (2015)

A simeprevir-inducible molecular switch for the control of cell and gene therapies
por: Chin, Stacey E., et al.
Publicado: (2023)

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
por: Ouwerkerk-Mahadevan, Sivi, et al.
Publicado: (2015)

Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
por: Khemichian, Saro, et al.
Publicado: (2015)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir
por: Gaetano, John N
Publicado: (2014)

Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis
por: Nguyen, Nghia H, et al.
Publicado: (2016)

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
por: Gaeta, Giovanni Battista, et al.
Publicado: (2018)

Photo-induced drug eruption in a patient on combination simeprevir/sofosbuvir for hepatitis C
por: Eyre, Zachary W., et al.
Publicado: (2016)

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir
por: Ascha, Mustafa, et al.
Publicado: (2015)

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
por: Issa, D., et al.
Publicado: (2016)

Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials
por: Yee, Brittany E, et al.
Publicado: (2016)

Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4
por: Abdel-Moneim, Adel, et al.
Publicado: (2019)

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir
por: Ramzy, Sherif, et al.
Publicado: (2022)

Vibrio cholerae Motility in Aquatic and Mucus-Mimicking Environments
por: Grognot, Marianne, et al.
Publicado: (2021)

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
por: Walker, David R, et al.
Publicado: (2015)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications
por: Marra, Fiona, et al.
Publicado: (2018)

Combination Therapy of Simeprevir and Sofosbuvir in Recurrent HCV Genotype 4 After Liver Retransplantation: Case Report
por: Obed, Aiman, et al.
Publicado: (2016)

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice
por: Muturi, Elishiba, et al.
Publicado: (2022)

Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B
por: Nakayama, Shinji, et al.
Publicado: (2023)

The American Society for Reproductive Medicine Embryo Transfer Simulator Initiative has come full circle: an editorial
por: Reindollar, Richard H.
Publicado: (2023)

Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients
por: Watanabe, Takao, et al.
Publicado: (2016)

Pharmacokinetics, safety, and tolerability of the 2‐ and 3‐direct‐acting antiviral combination of AL‐335, odalasvir, and simeprevir in healthy subjects
por: Kakuda, Thomas N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_50lmgqq46rqv42cq554f4b6340